D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 76 Citations 20,964 167 World Ranking 396 National Ranking 7

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • DNA

Dominique Sanglard mainly focuses on Candida albicans, Microbiology, Corpus albicans, Gene and Fluconazole. His Candida albicans study incorporates themes from Biochemistry, Saccharomyces cerevisiae, Yeast and Mutant. His studies deal with areas such as Efflux and ATP-binding cassette transporter as well as Microbiology.

His Corpus albicans study combines topics in areas such as Fungal protein and Virulence. His study with Gene involves better knowledge in Genetics. In his study, Cytochrome P450 is strongly linked to Lanosterol, which falls under the umbrella field of Fluconazole.

His most cited work include:

  • Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. (705 citations)
  • Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences (646 citations)
  • Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. (515 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Microbiology, Candida albicans, Corpus albicans, Gene and Biochemistry. His study focuses on the intersection of Microbiology and fields such as Virulence with connections in the field of Wild type. His Candida albicans research incorporates elements of ATP-binding cassette transporter, Mutant, Fungal protein, Efflux and In vivo.

His research in Corpus albicans is mostly concerned with Oropharyngeal Candidiasis. His work in Gene covers topics such as Molecular biology which are related to areas like Nucleic acid sequence and Locus. His study explores the link between Drug resistance and topics such as Antifungal drug that cross with problems in Pharmacology.

He most often published in these fields:

  • Microbiology (54.24%)
  • Candida albicans (47.46%)
  • Corpus albicans (30.93%)

What were the highlights of his more recent work (between 2016-2021)?

  • Microbiology (54.24%)
  • Candida albicans (47.46%)
  • Corpus albicans (30.93%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Microbiology, Candida albicans, Corpus albicans, Gene and Genetics. His research integrates issues of In vitro and In vivo in his study of Microbiology. His Candida albicans research is multidisciplinary, incorporating elements of Biochemistry, Echinocandin, Flavones and Cell biology.

His work on Oropharyngeal Candidiasis as part of his general Corpus albicans study is frequently connected to Oral mucosa, thereby bridging the divide between different branches of science. His Yarrowia, Virulence and Transcriptional regulation study in the realm of Gene connects with subjects such as Fitness function and Set. His research investigates the link between Fluconazole and topics such as Human pathogen that cross with problems in Drug resistance and Intensive care.

Between 2016 and 2021, his most popular works were:

  • Worldwide emergence of resistance to antifungal drugs challenges human health and food security. (352 citations)
  • Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens. (49 citations)
  • Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms (39 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

His main research concerns Microbiology, Candida albicans, In vivo, Corpus albicans and In vitro. Dominique Sanglard combines subjects such as Mutation and Opportunistic pathogen with his study of Microbiology. Candida albicans and Oral mucosa are two areas of study in which Dominique Sanglard engages in interdisciplinary work.

Dominique Sanglard interconnects Amphotericin B, Antifungal, Medical mycology and Fungal biofilm in the investigation of issues within In vivo. He works in the field of Corpus albicans, focusing on Oropharyngeal Candidiasis in particular. His research in Fluconazole intersects with topics in Galleria mellonella, Allele and Candida tropicalis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

D. Sanglard;Frank Christopher Odds.
Lancet Infectious Diseases (2002)

991 Citations

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

D Sanglard;K Kuchler;F Ischer;J L Pagani.
Antimicrobial Agents and Chemotherapy (1995)

958 Citations

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

Dominique Sanglard;Françoise Ischer;Michel Monod;Jacques Bille.
Microbiology (1997)

674 Citations

Amino Acid Substitutions in the Cytochrome P-450 Lanosterol 14α-Demethylase (CYP51A1) from Azole-Resistant Candida albicans Clinical Isolates Contribute to Resistance to Azole Antifungal Agents

Dominique Sanglard;Françoise Ischer;Luc Koymans;Jacques Bille.
Antimicrobial Agents and Chemotherapy (1998)

610 Citations

Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients

Sofia Perea;José L. López-Ribot;William R. Kirkpatrick;Robert K. McAtee.
Antimicrobial Agents and Chemotherapy (2001)

594 Citations

Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.

D Sanglard;F Ischer;M Monod;J Bille.
Antimicrobial Agents and Chemotherapy (1996)

453 Citations

Worldwide emergence of resistance to antifungal drugs challenges human health and food security.

Matthew C. Fisher;Nichola J. Hawkins;Dominique Sanglard;Sarah J. Gurr;Sarah J. Gurr.
Science (2018)

437 Citations

The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Dominique Sanglard;Françoise Ischer;David Calabrese;Paul A. Majcherczyk.
Antimicrobial Agents and Chemotherapy (1999)

397 Citations

Antifungal drug resistance in pathogenic fungi.

H Vanden Bossche;F Dromer;I Improvisi;M Lozano-Chiu.
Medical Mycology (1998)

392 Citations

A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans

Alix T. Coste;Vincent Turner;Françoise Ischer;Joachim Morschhäuser.
Genetics (2006)

386 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Dominique Sanglard

Bernhard Hube

Bernhard Hube

Leibniz Association

Publications: 148

Rajendra Prasad

Rajendra Prasad

Amity University

Publications: 130

Neil A. R. Gow

Neil A. R. Gow

University of Exeter

Publications: 84

Joachim Morschhäuser

Joachim Morschhäuser

University of Würzburg

Publications: 79

Alistair J. P. Brown

Alistair J. P. Brown

University of Exeter

Publications: 74

Scott G. Filler

Scott G. Filler

University of California, Los Angeles

Publications: 74

Joseph Heitman

Joseph Heitman

Duke University

Publications: 69

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 65

Michel Monod

Michel Monod

University Hospital of Lausanne

Publications: 64

Judith Berman

Judith Berman

Tel Aviv University

Publications: 64

Leah E. Cowen

Leah E. Cowen

University of Toronto

Publications: 64

Christophe d'Enfert

Christophe d'Enfert

Institut Pasteur

Publications: 62

Theodore C. White

Theodore C. White

University of Missouri–Kansas City

Publications: 52

Richard D. Cannon

Richard D. Cannon

University of Otago

Publications: 51

John R. Perfect

John R. Perfect

Duke University

Publications: 51

Steven L. Kelly

Steven L. Kelly

Swansea University

Publications: 50

Something went wrong. Please try again later.